May 4, 2020 / 11:17 AM / 25 days ago

BRIEF-Diamyd Presents Findings From Part Of Clinical Trial With Remygen

May 4 (Reuters) - Diamyd Medical AB:

* PROMISING FINDINGS FROM THE FIRST PART OF A CLINICAL TRIAL WITH REMYGEN[®]

* PRESENTS PRELIMINARY RESULTS SHOWING THAT TRIAL PARTICIPANTS’ BLOOD SUGAR CONTROL IMPROVED OVER NINE-DAY TREATMENT PERIOD.

* RESULTS ALSO SUPPORT A SURPRISING PROTECTIVE EFFECT OF REMYGEN(®) DURING HYPOGLYCAEMIA, THAT IS, DURING SHARPLY LOWERED BLOOD SUGAR LEVELS

* PATENT-PENDING RESULTS SHOW THAT TIME THAT PARTICIPANTS SPENT IN TARGET RANGE FOR BLOOD SUGAR INCREASED DURING TREATMENT

* RESULTS SURPRISINGLY SHOW THAT PROTECTIVE MECHANISMS THAT COUNTERACT HYPOGLYCEMIA IMPROVED DURING TREATMENT PERIOD Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below